Legal Status
Where psychedelics stand legally is complicated, and it changes fast. Here's the honest shape of it.
United States — federal
Psilocybin, LSD, MDMA and most classic psychedelics are Schedule I under federal law — the most restrictive tier, officially defined as having no accepted medical use and a high potential for abuse. A growing body of research challenges that label, but it still stands. The April 2026 executive order pushed federal agencies to speed up research and review — but it rescheduled nothing and legalized nothing.
United States — state and local
Below the federal level it's a patchwork. Oregon (voter-approved in 2020, launched 2023) and Colorado (2022, licensing from late 2024) run regulated programs where an adult can take psilocybin with a trained facilitator at a licensed center — supervised access, not retail sale. A number of cities, Denver and Oakland among the first, have decriminalized personal possession, which lowers enforcement priority without making anything legal. State-legal is never the same as federally legal.
Around the world
Australia became the first country to let authorised psychiatrists prescribe MDMA for PTSD and psilocybin for treatment-resistant depression, starting July 2023 — narrow, medical, and prescriber-gated. Elsewhere it ranges from quietly decriminalized to strictly prohibited, with no global consistency.
The only law that matters is yours
None of this is legal advice. In most places, possession is still a crime. These rules shift constantly and vary by country, state, and even city — check your own jurisdiction before assuming anything.